CosmicTaco

The Looming Fiscal Crisis Over Revolutionary Weight Loss Drugs

CosmicTaco · 2024-10-22T15:55:33.131249+05:30

- America faces a fiscal crisis over revolutionary weight loss drugs like Ozempic and Wegovy. - These drugs, produced by Novo Nordisk, have potential cardiovascular, mental health, and anti-cancer benefits. - However, their high cost in the U.S. compared to other countries could bankrupt Medicare. - If half of U.S. adults with obesity took these drugs, it would cost $411 billion annually. - The State Treasurer of North Carolina, Dale Folwell, is questioning the high cost and has asked the federal government to negotiate with Novo Nordisk to open up patents to generic manufacturers. Source: [More Perfect Union](https://youtu.be/JqHmvMjXuro)

America faces a fiscal crisis over revolutionary weight loss drugs like Ozempic and Wegovy.
These drugs, produced by Novo Nordisk, have potential cardiovascular, mental health, and anti-cancer benefits.
However, their high cost in the U.S. compared to other countries could bankrupt Medicare.
If half of U.S. adults with obesity took these drugs, it would cost $411 billion annually.
The State Treasurer of North Carolina, Dale Folwell, is questioning the high cost and has asked the federal government to negotiate with Novo Nordisk to open up patents to generic manufacturers.

Source: More Perfect Union

9mo ago

Jobs

One interview, 1000+ job opportunities

Take a 10-min AI interview to qualify for numerous real jobs auto-matched to your profile 🔑

+322 new users this month

You're early. There are no comments yet.

Be the first to comment.

Discover more

Curated from across

News Discussion10mo

by CosmicTacoGrapevine

Ozempic Revolution: A Boon for Gyms and Health Clubs

The success of weight loss and diabetes drugs like Ozempic, Wegovy, and Zepbound is expected to boost gym memberships.
These drugs, projected to generate $50bn in sales this year, could lead to a consumer rush towards strength train...

News Discussion10mo

by CosmicTacoGrapevine

Obesity Drugs: Miracle Cure or Overhyped Solution?

Scientists are exploring the potential of obesity drugs to treat various ailments, from alcoholism to Parkinson's disease.
GLP-1 receptor agonists, a class of weight-loss drugs, show promise in reducing cravings for substances like a...

News Discussion5mo

by CosmicTacoGrapevine

Indian Pharma Giants Bet on Ozempic Copy Amid Revenue Decline

Natco Pharma and Dr. Reddy's shift focus to weight-loss drug Ozempic's generic version to counter revenue drop from Revlimid.
Natco's shares fell 30% post weak Q3 earnings; Dr. Reddy's profits from Revlimid face future decline.
Bot...